Stanley Westreich - Curasan AG Insider

Curasan AG -- Germany Stock  

EUR 1.31  0.06  4.8%

Independent Director

Mr. Stanley I. Westreich is Independent Director of Neuralstem Inc. since February 15 2011
Age: 77  Director Since 2011      
49 60 2740 9000  http://www.curasan.de
Westreich is the manager of Westreich Services, LLC, a private investment and advisory firm which he founded in 2005. Prior to founding Westreich Services, LLC, Mr. Westreich was President of Westfield Realty, Inc., a real estate development and construction company, from 1965 to 2005. From July 26, 1994 to May 2010 he served as a director of Capital One Financial Corporationrationrationration and also served as a director of Capital One Bank, National Association. He served as a member of the Capital One Financial Corporationrationrationration Compensation Committee from March 1995 through February 2010 and was its Chairman from March 1995 through April 2005. He has also served on the Capital One Financial Corporationrationrationration Finance and Trust Oversight Committee from April 2004 to May of 2010.

Management Efficiency

The company has return on total asset (ROA) of (15.0) % which means that it has lost $15.0 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (35.94) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 427 K in total debt with debt to equity ratio (D/E) of 6.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Curasan AG has Current Ratio of 1.29 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.

Similar Executives

Entity Summary

curasan AG develops, produces, and markets medical solutions worldwide. Curasan AG (CUR) is traded on Frankfurt Stock Exchange in Germany. It is located in Kleinostheim, and employs 33 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Curasan AG to your portfolio

Top Management

Curasan AG Leadership Team
William Oldaker, Director
David Castaneda, Executive
Stanley Westreich, Director
Karl Johe, Chairman
Scott Ogilvie, Director
I Garr, CEO
Catherine Sohn, Director, Ph.D
Richard Garr, CEO
Richard Daly, CEO, MBA
Sandford Smith, Director
Jonathan Jones, CFO

Stock Performance

Curasan AG Performance Indicators